We found that obesity-induced alterations in β-cell mass and proliferation were inhibited by chronic GLP-1 (7–36) or liraglutide treatment without altering food intake or body weight. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.